Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma

Immune checkpoint inhibitors targeting programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 have improved survival in patients with metastatic melanoma, especially in combination (i.e., ipilimumab-nivolumab). Postmarketing surveillance has identified rare but at times life...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazel, Mahdieh, Jedlowski, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515062/
https://www.ncbi.nlm.nih.gov/pubmed/31183226
http://dx.doi.org/10.1155/2019/2539493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515062/
https://www.ncbi.nlm.nih.gov/pubmed/31183226
http://dx.doi.org/10.1155/2019/2539493

Ejemplares similares